Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB5459

Caption

A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.

Companion Bills

No companion bills found.

Similar Bills

US SB1096

Preserve Access to Affordable Generics and Biosimilars Act

US SB1040

Drug Competition Enhancement Act

US HB9184

Patient Access Act of 2024

US HB3546

Prescription Drug Price Relief Act of 2025

US HB8261

Preserving Telehealth, Hospital, and Ambulance Access Act

US SB1095

Stop STALLING Act Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act

US SB5638

A bill to secure the supply of drugs in the United States, and for other purposes.

US HB8848

Affordable and Safe Prescription Drug Importation Act of 2024